I see it happens to make their screen for job
growth as well, coming in at number two on
a percentage basis.
money.cnn.com
Well, I'll read their annual report when it is online.
Here is an article from Investors Business Daily
investors.com
At the least Precigen will be something to follow
after it is spun off. I have only followed this very casually.
The story hasn't probably changed much, it just gets
confusing, GNSC--Hapmap, CLDA--biomarkers etc etc.
pgxhealth.com
Clinical Data initiated the first pivotal trial for vilazodone in February 2006 in which genetic biomarkers for response to vilazodone will be identified.
clinicaltrials.gov
This randomized, double-blind, placebo-controlled, multicenter, 8-week, clinical trial is designed to assess the efficacy and safety of vilazodone and to discover genetic markers of treatment response associated with vilazodone use in adult patients diagnosed with MDD by the DSM-IV-TR criteria. This study will enroll approximately 400 patients
Cart before the horse? Surely Genaissance, I mean
Clinical Data, I mean PGXHealth, is verifying
biomarkers--not hoping to finally find something.
pgxhealth.com
genaissance.com |
